MBX Biosciences Inc (NASDAQ: MBX) is -33.48% lower on its value in year-to-date trading and has touched a low of $9.42 and a high of $27.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MBX stock was last observed hovering at around $11.25 in the last trading session, with the day’s gains setting it 1.01%.
Currently trading at $12.26, the stock is 8.18% and -25.17% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.94 million and changing 8.98% at the moment leaves the stock -36.57% off its SMA200. The firm has a 50-day simple moving average (SMA 50) of $16.4678 and a 200-day simple moving average (SMA200) of $19.400404.
The stock witnessed a -24.69% in the last 1 month and extending the period to 3 months gives it a -43.92%, and is 5.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.39% over the week and 11.93% over the month.
Distance from 52-week low is 30.09% and -55.42% from its 52-week high.
The shares outstanding are 33.38M, and float is at 16.24M with Short Float at 12.50%.
MBX Biosciences Inc (MBX) Insider Activity
The most recent transaction is an insider purchase by Hawryluk P. Kent, the company’s President & CEO. SEC filings show that Hawryluk P. Kent bought 50,000 shares of the company’s common stock on Feb 04 ’25 at a price of $10.69 per share for a total of $0.53 million. Following the purchase, the insider now owns 0.45 million shares.
MBX Biosciences Inc disclosed in a document filed with the SEC on Sep 16 ’24 that Mathers Edward T (Director) bought a total of 500,000 shares of the company’s common stock. The trade occurred on Sep 16 ’24 and was made at $16.00 per share for $8.0 million. Following the transaction, the insider now directly holds 3.61 million shares of the MBX stock.
Still, SEC filings show that on Sep 16 ’24, BASKETT FOREST (10% Owner) acquired 500,000 shares at an average price of $16.00 for $8.0 million. The insider now directly holds 3,614,486 shares of MBX Biosciences Inc (MBX).
